Stockfarming: prohibition of certain substances with hormonal or thyrostatic action, of beta-agonists

The European Parliament adopted some of the amendments in the report by Karl Erik OLSSEN (ELDR, Sweden). The amendments were designed to phase out the use of oestradiol 17 for oestrus induction over three years. However, the use of oestradiol for the treatment of certain conditions (foetus maceration or mummification or pyrometra in cattle) is maintained under strict conditions.�